[ FDA ENFORCEMENT INTELLIGENCE ]
Learn from the record. Every FDA recall is a quality signal.
Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.
1,000
Total recalls
217
Class I (most serious)
167
Drug
515
Device
318
Food / supplement / cosmetic
Last 12 months · latest report 2026-07-22 · source: openFDA enforcement
RECALLS BY CLASSIFICATION · MONTHLY
RECALL REASONS BY QUALITY DOMAIN
Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.
1,235 matching recalls
| Date | Class | Firm | Reason | Quality domain |
|---|---|---|---|---|
| 2026-07-08 | Class II | Asclemed USA Inc.D-0658-2026 | Lack of Assurance of Sterility | Environmental Monitoring |
| 2026-07-08 | Class II | Asclemed USA Inc.D-0659-2026 | Lack of Assurance of Sterility | Environmental Monitoring |
| 2026-07-08 | Class II | DEPUY (IRELAND)Z-2616-2026 | The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility. | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0647-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0643-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | DEPUY (IRELAND)Z-2617-2026 | The external sterile packaging was found adhered to the internal sterile packaging, potentially compromising sterility. | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0649-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0648-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | Blaine Labs IncD-0699-2026 | CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated | Environmental Monitoring |
| 2026-07-08 | Class I | NARA ORGANICS INCH-1137-2026 | Product may be contaminated with Clostridium botulinum. | Environmental Monitoring |
| 2026-07-08 | Class I | Windstone Medical Packaging, Inc.Z-2620-2026 | Kits contain Webcol Large Alcohol Prep Pad which were recalled by Cardinal Health following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit. | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0645-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | Boston Scientific CorporationZ-2627-2026 | Potential sterile breach of the pouches in which devices are packaged. | Environmental Monitoring |
| 2026-07-08 | Class II | Blaine Labs IncD-0693-2026 | CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated | Environmental Monitoring |
| 2026-07-08 | Class II | Boston Scientific CorporationZ-2636-2026 | Potential sterile breach of the pouches in which devices are packaged. | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0646-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | MARS SNACKINGH-1129-2026 | Potential contamination with plastic material | Environmental Monitoring |
| 2026-07-08 | Class II | Boston Scientific CorporationZ-2626-2026 | Potential sterile breach of the pouches in which devices are packaged. | Environmental Monitoring |
| 2026-07-08 | Class I | Windstone Medical Packaging, Inc.Z-2622-2026 | Kits contain Webcol Large Alcohol Prep Pad which were recalled by Cardinal Health following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit. | Environmental Monitoring |
| 2026-07-08 | Class II | Boston Scientific CorporationZ-2628-2026 | Potential sterile breach of the pouches in which devices are packaged. | Environmental Monitoring |
| 2026-07-08 | Class II | CareFusion 213, LLCD-0650-2026 | Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel | Environmental Monitoring |
| 2026-07-08 | Class II | TELEFLEX LLCZ-2639-2026 | Due to out-of-specification, or potential out-of-specification, levels of endotoxins | Environmental Monitoring |
| 2026-07-08 | Class II | Boston Scientific CorporationZ-2630-2026 | Potential sterile breach of the pouches in which devices are packaged. | Environmental Monitoring |
| 2026-07-08 | Class II | Zimmer Surgical IncZ-2674-2026 | Potential sterility breach in sealing area of sterile pouch. If used, issue may result in moderate localized infection. If discovered prior to use, may result in clinically insignificant extension of surgery to find another readily available device. | Environmental Monitoring |
| 2026-07-08 | Class I | Medline Industries, LPZ-2615-2026 | Expansion of RES 98277. Specific lots of reprocessed catheters may contain small particles of residual material. If devices with residual particulates on patient-contacting surfaces are used, there is a potential risk of an inflammatory response or systemic infection. If particulate were to dislodge during use and contact circulating blood or the heart, it may produce a granulomatous reaction or thrombus formation, which may lead to cerebral or pulmonary embolism, or deep vein thrombosis. | Environmental Monitoring |
Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.